510(k) Report

510(k) · Cleared

Recalled · Class II · 2026

Medegen Pressure Rated Extension Sets

K083472510(k) TraditionalCleared Dec 9, 200815-day reviewClass II21 CFR 880.5440Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medegen, Inc. · FPA Set, Administration, Intravascular

Cleared on Dec 9, 2008 after a 15-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 32 later devices descend from it. It has been recalled 2 times.

Decided
Dec 9, 2008
Review
15 days
Class
Class II
Product code
FPA
Recalls
2
Predicates
0

32 later devices descend from it, 4 citing it directly.

Descendants, by year cleared 2016: 1 descendant cleared2009: 1 descendant cleared2012: 1 descendant cleared2014: 3 descendants cleared2013: 2 descendants cleared2020: 2 descendants cleared2017: 4 descendants cleared2023: 3 descendants cleared2021: 7 descendants cleared2019: 2 descendants cleared2026: 2 descendants cleared2025: 2 descendants cleared2024: 1 descendant cleared2022: 1 descendant cleared20052010201520202025
  1. This deviceK083472 Medegen Pressure Rated Extension SetsMedegen, Inc. · 2008
  2. Descendant · cites it directly · 28 of its ownK120443 Neutral Luer Activated Device and Extension Sets with Neutral Luer…Baxter Healthcare Corporation - Renal Division · 2012
  3. Descendant · 2 generations on · 26 of its ownK132413 MZ1000Care Fusion · 2013
  4. Descendant · cites it directly · 13 of its ownK140831 Maxzero Extension Set with Needless ConnectorCare Fusion · 2014
  5. Descendant · 3 generations on · 6 of its ownK170336 BD Nexiva Closed IV Catheter System (Single Port) with MaxZero…Becton, Dickinson and Company · 2017
  6. Descendant · 4 generations on · 5 of its ownK183399 BD Nexiva Closed IV Catheter SystemBecton Dickinson Infusion Therapy Systems, Inc. · 2019 · Recalled

Showing 5 of 32 descendants. See all descendants

Descendants cleared per year

2009: 12012: 12013: 22014: 32016: 12017: 42019: 22020: 22021: 72022: 12023: 32024: 12025: 22026: 2
2009high 7 (2021) · low 0 (2010)2026

Most influential descendants

Showing 5 of 32 · See all
  • K120443Neutral Luer Activated Device and Extension Sets with Neutral Luer Activated DeviceBaxter Healthcare Corporation - Renal Division · 2012 · cites it directly28descendants
  • K132413MZ1000Care Fusion · 2013 · 2 generations on26descendants
  • K140831Maxzero Extension Set with Needless ConnectorCare Fusion · 2014 · cites it directly13descendants
  • K170336BD Nexiva Closed IV Catheter System (Single Port) with MaxZero Needleless ConnectorBecton, Dickinson and Company · 2017 · 3 generations on6descendants
  • K183399BD Nexiva Closed IV Catheter SystemBecton Dickinson Infusion Therapy Systems, Inc. · 2019 · 4 generations on5descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K083472Medegen Pressure Rated Extension SetsMedegen, Inc.2008—
+1K120443Neutral Luer Activated Device and Extension Sets with Neutral Luer Activated…Baxter Healthcare Corporation - Renal Division2012—
+2K132413MZ1000Care Fusion2013—
+1K140831Maxzero Extension Set with Needless ConnectorCare Fusion2014—
+3K170336BD Nexiva Closed IV Catheter System (Single Port) with MaxZero Needleless…Becton, Dickinson and Company2017—
+4K183399BD Nexiva Closed IV Catheter SystemBecton Dickinson Infusion Therapy Systems, Inc.20193

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200910
201210
201320
201430
201610
201740
201920
202020
202170
202210
202330
202410
202520
202620
FIG. 1 — Lineage of K083472, 2008–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (32)

See all 32

4 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K120443Neutral Luer Activated Device and Extension Sets with Neutral Luer Activated DeviceBaxter Healthcare Corporation - Renal Division201228
K140831Maxzero Extension Set with Needless ConnectorCare Fusion201413
K153293Extension SetB.Braun Medical, Inc.20163
K090809MPS Acacia Power Injectable Infusion SetMps Acacia20092

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jun 16, 2026Class IIZ-2941-2026Process controlDue to mechanical issue with internal sterilization equipment resulting in potential underdosing of product during processing, which may have resulted in products not being sterilized correctly.
May 2, 2019Class IIZ-0049-2020Under Investigation by firmAfter disconnection of a luer, the valve of the connector remains recessed; not fully closing, either temporarily or permanently. The risks of blood loss and air embolism exist if the valve remains permanently open and goes undetected…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K120443 (Baxter Healthcare Corporation - Renal Division, 2012) has gone furthest, with 28 descendants of its own.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—

What is it indicated for?

The Medegen Pressure Rated Extension Sets are intended for use in today's

growing professional healthcare environment, including healthcare facilities,

home care and medical transport that utilize infusion systems for the delivery of

fluids, medications, blood and blood products. The Medegen Pressure Rated

Extension Sets allow the user to add medication into the primary line without the

use of a needle. The Medegen Pressure Extension Sets may also be used with

low-pressure power injectors rated up to 325 psi.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K083472: Medegen Pressure Rated Extension Sets.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K083472

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026